Literature DB >> 27122918

Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.

Chieh-Shou Su1, Kuan-Ju Chen2, Wayne Huey-Herng Sheu3, Ya-Ling Yang4, Tsun-Jui Liu1, Wei-Chun Chang1, Kuo-Yang Wang5, Wen-Lieng Lee1.   

Abstract

BACKGROUND: The atheroprotective role of high-density lipoprotein (HDL-C) particles as measured by HDL-C level in coronary arterial disease (CAD) remains unsettled. The aim of our study was to ascertain whether HDL-C was associated with the development and severity of coronary artery disease in Chinese patients who underwent coronary angiogram with low background Low-density lipoprotein (LDL-C) levels, which has not been previously investigated.
METHODS: Between March 1995 and May 2000, 566 consecutive patients (408 males, 66.7 ± 11.3 years of age) with background LDL-C less than 100 mg/dl who underwent coronary artery angiography at our cath lab for suspected CAD were retrospectively recruited into the study. The severity of coronary lesions was measured by conventional coronary angiography and modified Gensini scores.
RESULTS: In those subjects with significant coronary lesions, there were more males and conventional CAD risk factors of diabetes mellitus, smoking, and chronic renal disease. They were also older compared to those in the control group. However, total cholesterol, LDL-C, HDL-C, triglyceride levels and use of statins were similar in both groups. In those subjects with significant coronary lesions, there was no difference in conventional coronary lesion severity or modified Gensini score between the quartered HDL-C subgroups. Furthermore, there was no significant correlation between serum HDL-C level and modified Gensini scores. In linear regression analysis, HDL-C was not an independent predictor for modified Gensini scores. Furthermore, HDL-C was also not an independent risk factor for the presence of significant coronary lesions in low LDL-C patients in logistic regression analysis.
CONCLUSIONS: In Chinese patients with low background LDL-C, serum HDL-C was not associated with development of CAD or lesion severity in patients with suspected CAD. Therefore, HDL-C did not appear to be atheroprotective in these patients. KEY WORDS: Coronary artery disease; Gensini score; High-density lipoprotein cholesterol.

Entities:  

Year:  2015        PMID: 27122918      PMCID: PMC4804978          DOI: 10.6515/acs20150421a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  31 in total

Review 1.  Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.

Authors:  P K Shah; S Kaul; J Nilsson; B Cercek
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.

Authors:  Emil M deGoma; Nicholas J Leeper; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2008-01-01       Impact factor: 24.094

4.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

7.  High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.

Authors:  H F Alber; M M Wanitschek; S de Waha; A Ladurner; A Suessenbacher; J Dörler; W Dichtl; M Frick; H Ulmer; O Pachinger; F Weidinger
Journal:  Eur J Clin Invest       Date:  2008-06       Impact factor: 4.686

Review 8.  Endothelial protection by high-density lipoproteins: from bench to bedside.

Authors:  Laura Calabresi; Monica Gomaraschi; Guido Franceschini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-11       Impact factor: 8.311

9.  Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Authors:  Nadeem Sarwar; John Danesh; Gudny Eiriksdottir; Gunnar Sigurdsson; Nick Wareham; Sheila Bingham; S Matthijs Boekholdt; Kay-Tee Khaw; Vilmundur Gudnason
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

10.  Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  Russell Scott; Richard O'Brien; Greg Fulcher; Chris Pardy; Michael D'Emden; Dana Tse; Marja-Riitta Taskinen; Christian Ehnholm; Anthony Keech
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 19.112

View more
  2 in total

1.  High-density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension.

Authors:  Xiaopu Wang; Junyu Pei; Keyang Zheng; Xinqun Hu
Journal:  Clin Cardiol       Date:  2021-03-30       Impact factor: 2.882

2.  Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.

Authors:  Guisong Wang; Anna Vachaparampil Mathew; Haiyi Yu; Lei Li; Liyun He; Wei Gao; Xiaodan Liu; Yanhong Guo; Jaeman Byun; Jifeng Zhang; Y Eugene Chen; Subramaniam Pennathur
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.